Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07376889 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Combination Antibiotic Therapy for Staphylococcus Aureus Bacteremia

Study acronym: COMBAT-SAB
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 7 words
    • Site details revised at 12 of 13 sites
  2. Recruitment opened
    • Site details revised at 13 of 13 sites
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to see if, in selected patients with a serious bacterial infection of the bloodstream, treating the bacterial infection with a combination of antibiotics is more effective than treating the infection with a single antibiotic. Participants must have blood cultures which are positive for a certain type of bacteria.
Trial Details
NCT Number NCT07376889
Lead Sponsor Intermountain Health Care, Inc.
Conditions
(from sponsor)		 Staphylococcus Aureus Bacteremia
Enrollment 2,096 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov